Tris Pharma
Payal Naik, MPH, serves as the Medical Affairs Project Lead at Tris Pharma since December 2019, overseeing the planning of annual congresses and meetings, summarizing field insights for business strategy, and contributing to the development of medical publications and communications. Naik has also managed Phase I Pharmacokinetic studies and provided medical insights for various publication strategies related to CNS products. Previous roles include positions as a Medical Scribe at GARDEN STATE UROLOGY LLC, Princeton Gastroenterology, and St. Francis Hospital, along with an internship at the Turner Syndrome Foundation. Naik holds a Master of Public Health in Epidemiology from Rutgers University–New Brunswick and a Bachelor of Science in Biology with a minor in Psychology from Seton Hall University.
This person is not in any offices
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.